Log In
BCIQ
Print this Print this
 

Janus kinase-2 (JAK-2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Janus kinase-2 (JAK-2)

BCIQ
Print ChartPrint this
0 0 0 1 0 0 1 0 0 0 0 0 2 1 3 2 2 1 1 1 1 3 1 0 2 1 0 3 1 0
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

2

1

0

3

1

0

Cancer

1

1

1

3

1

0

Hematology

2

1

3

2

2

1

Inflammation

1

0

0

0

0

0

Renal

0

0

0

1

0

0




 Products Targeting Janus kinase-2 (JAK-2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

10

$3,447.8M

$963.4M

$3,269.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today